Cargando…
The OECD Program to Validate the Rat Hershberger Bioassay to Screen Compounds for in Vivo Androgen and Antiandrogen Responses: Phase 2 Dose–Response Studies
OBJECTIVE: The Organisation for Economic Co-operation and Development (OECD) has completed phase 2 of an international program to validate the rodent Hershberger bioassay. DESIGN: The Hershberger bioassay is designed to identify suspected androgens and antiandrogens based on changes in the weights o...
Autores principales: | Owens, William, Gray, L. Earl, Zeiger, Errol, Walker, Michael, Yamasaki, Kanji, Ashby, John, Jacob, Elard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1867976/ https://www.ncbi.nlm.nih.gov/pubmed/17520051 http://dx.doi.org/10.1289/ehp.9666 |
Ejemplares similares
-
The OECD Program to Validate the Rat Hershberger Bioassay to Screen Compounds
for in Vivo Androgen and Antiandrogen Responses. Phase 1: Use of a Potent Agonist
and a Potent Antagonist to Test the Standardized Protocol
por: Owens, William, et al.
Publicado: (2006) -
OECD validation of the Hershberger assay in Japan: phase 2 dose response of methyltestosterone, vinclozolin, and p,p'-DDE.
por: Yamasaki, Kanji, et al.
Publicado: (2003) -
The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies.
por: Kanno, Jun, et al.
Publicado: (2003) -
The OECD program to validate the rat uterotrophic bioassay. Phase 2: coded single-dose studies.
por: Kanno, Jun, et al.
Publicado: (2003) -
The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1.
por: Kanno, J, et al.
Publicado: (2001)